Shane C Burgess

Shane C Burgess

Dean, Charles-Sander - College of Agriculture and Life Sciences
Vice President, Agriculture - Life and Veterinary Sciences / Cooperative Extension
Professor, Animal and Comparative Biomedical Sciences
Professor, Immunobiology
Professor, BIO5 Institute
Member of the General Faculty
Member of the Graduate Faculty
Primary Department
Department Affiliations
Contact
(520) 621-7621

Research Interest

Shane C. BurgessVice President for Agriculture, Life and Veterinary Sciences, and Cooperative ExtensionDean, College of Agriculture and Life SciencesInterim Dean, School of Veterinary MedicineDirector, Arizona Experiment StationA native of New Zealand, Dr. Burgess has worked around the world as a practicing veterinarian and scientist. His areas of expertise include cancer biology, virology, proteomics, immunology and bioinformatics.Since 1997 he has 186 refereed publications, trained 37 graduate students and has received nearly $55 million in competitive funding.The first in his extended family to complete college, Dr. Burgess graduated with distinction as a veterinarian in 1989 from Massey University, New Zealand. He has worked in, and managed veterinary clinical practices in Australia and the UK, including horses, farm animals, pets, wild and zoo animals, and emergency medicine and surgery. He did a radiology residency at Murdoch University in Perth in Western Australia, where he co-founded Perth's first emergency veterinary clinic concurrently. He has managed aquaculture facilities in Scotland. He did his PhD in virology, immunology and cancer biology, conferred by Bristol University medical school, UK while working full time outside of the academy between 1995 and 1998. Dr. Burgess volunteered to work in the UK World Reference Laboratory for Exotic Diseases during the 2001 UK foot and mouth disease crisis, where he led the diagnosis reporting office, for the Office of the UK Prime Minister Tony Blair. He was awarded the Institute for Animal Health Director's Award for Service.In 2002, Dr. Burgess joined Mississippi State University’s College of Veterinary Medicine as an assistant professor. He was recruited from Mississippi State as a professor, an associate dean of the college and director of the Institute for Genomics, Biocomputing and Biotechnology to lead the UA College of Agriculture and Life Sciences in July 2011. Under Dr. Burgess’ leadership, the college has a total budget of more than $120M with over 3,400 students and more than 1,800 employees.

Publications

Parvizi, P., Read, L. R., Abdul-Careem, M., Sarson, A. J., Lusty, C., Lambourne, M., Thanthrige-Don, N., Burgess, S. C., & Sharif, S. (2009). Cytokine gene expression in splenic CD4+ and CD8+ T cell subsets of genetically resistant and susceptible chickens infected with Marek's disease virus. Veterinary Immunology and Immunopathology, 132(2-4), 209-217.

PMID: 19615758;Abstract:

T cells from the spleens of B19/B19 and B21/B21 chickens infected with MDV JM-16 strain were fractionated by flow cytometry at 4, 10, 21 days post infection (d.p.i.). The expression of cytokine and viral genes (meq and glycoprotein B (gB)) was measured by real-time RT-PCR. It was determined that CD4+ and CD8+ T cells had both become infected with Marek's disease virus (MDV) in both chicken lines. There was significantly higher expression of meq in CD4+ T cells compared to CD8+ T cells at 10 and 21 d.p.i. Furthermore, at 10 and 21 d.p.i., there was a tendency for higher expression of meq in both T cell subsets of B19 chickens compared to those of B21 chickens. There were temporal changes in the expression of cytokines, interferon (IFN)-γ, interleukin (IL)-18, IL-6, and IL-10, in various T cell subsets. Among these changes, there was an increase in IL-10 expression in both T cell subsets at different time points, especially in the susceptible line at 10 and 21 d.p.i. Our results indicate that cytokines could be differentially induced by MDV in CD4+ and CD8+ T cell subsets and that IL-10 may play a role in the modulation of immune response to MDV. However, an association between cytokine gene expression in T cell subsets and resistance or susceptibility to MD was not established. © 2009 Elsevier B.V. All rights reserved.

Kunec, D., Hanson, L. A., Haren, S. V., Nieuwenhuizen, I. F., & Burgess, S. C. (2008). An overlapping bacterial artificial chromosome system that generates vectorless progeny for channel catfish herpesvirus. Journal of Virology, 82(8), 3872-3881.

PMID: 18234790;PMCID: PMC2292985;Abstract:

Herpesviruses are important pathogens of humans and other animals. Herpesvirus infectious clones that can reconstitute phenotypically wild-type (wt) virus are extremely valuable tools for elucidating the roles of specific genes in virus pathophysiology as well as for making vaccines. Ictalurid herpesvirus 1 (channel catfish herpesvirus [CCV]) is economically very important and is the best characterized of the herpesviruses that occur primarily in bony fish and amphibians. Here, we describe the cloning of the hitherto recalcitrant CCV genome as three overlapping subgenomic bacterial artificial chromosomes (BACs). These clones allowed us to regenerate vectorless wt CCVs with a phenotype that is indistinguishable from that of the wt CCV from which the BACs were derived. To test the recombinogenic systems, we next used the overlapping BACs to construct a full-length CCV BAC by replacing the CCV ORF5 with the BAC cassette and cotransfecting CCO cells. The viral progeny that we used to transform Escherichia coli and the resulting BAC had only one of the 18-kb terminal repeated regions. Both systems suggest that one of the terminal repeat regions is lost during the replicative stage of the CCV life cycle. We also demonstrated the feasibility of introducing a targeted mutation into the CCV BAC infectious clone by constructing a CCV ORF12 deletion mutant and showed that ORF12 encodes a nonessential protein for virus replication. This is the first report of the generation of an infectious BAC clone of a member of the fish and amphibian herpesviruses and its use to generate recombinants. Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Xianyao, L. i., Swaggerty, C. L., Kogut, M. H., Chiang, H., Wang, Y., Genovese, K. J., Haiqi, H. e., McCarthy, F. M., Burgess, S. C., Pevzner, I. Y., & Zhou, H. (2012). Systemic response to Campylobacter jejuni infection by profiling gene transcription in the spleens of two genetic lines of chickens. Immunogenetics, 64(1), 59-69.

PMID: 21748442;Abstract:

Campylobacter jejuni (C. jejuni) is a leading cause of human bacterial enteritis worldwide with poultry products being a major source of C. jejuni contamination. The chicken is the natural reservoir of C. jejuni where bacteria colonize the digestive tract of poultry, but rarely cause symptoms of disease. To understand the systemic molecular response mechanisms to C. jejuni infection in chickens, total splenic RNA was isolated and applied to a whole genome chicken microarray for comparison between infected (I) and non-infected (N) chickens within and between genetic lines A and B. There were more total splenic host genes responding to the infection in resistant line A than in susceptible line B. Specifically, genes for lymphocyte activation, differentiation and humoral response, and Ig light and heavy chain were upregulated in the resistant line. In the susceptible line, genes for regulation of erythrocyte differentiation, hemopoiesis, and RNA biosynthetic process were all downregulated. An interaction analysis between genetic lines and treatment demonstrated distinct defense mechanisms between lines: the resistant line promoted apoptosis and cytochrome c release from mitochondria, whereas the susceptible line responded with a downregulation of both functions. This was the first time that such systemic defensive mechanisms against C. jejuni infection have been reported. The results of this study revealed novel molecular mechanisms of the systemic host responses to C. jejuni infection in chickens that warrant further investigation. © Springer-Verlag 2011.

Dail, M. B., Burgess, S. C., Meek, E. C., Wagner, J., Baravik, J., & Chambers, J. E. (2007). Spatial distribution of CYP2B1/2 messenger RNA within the rat liver acinus following exposure to the inducers phenobarbital and dieldrin. Toxicological Sciences, 99(1), 35-42.

PMID: 17517822;Abstract:

Traditionally, the liver has been considered a homogeneous organ, but literature suggests that the cytochromes P450 are differentially distributed among the hepatocytes and that the pattern of this distribution is altered by various xenobiotics. In this study, the CYP2B1/2 messenger RNA (mRNA) in the hepatocytes was compared following treatment of rats with either of two inducers, phenobarbital (PB), or dieldrin. Adult male Sprague-Dawley-derived rats were treated with either ip PB in saline at 80 mg/kg/day for 5 days or dieldrin in corn oil by oral gavage at 2.5 mg/kg/day for 13 days. Control rats received ip saline or po corn oil for the same time. Laser capture microdissection (LCM) followed by duplex quantitative real-time reverse transcriptase PCR was used to measure the CYP2B1/2 mRNA produced in bands of hepatocytes isolated from three locations along the sinusoidal path. The amounts of mRNA present in whole liver subsamples were also analyzed. CYP2B1/2 enzyme activity was determined by assaying 16β-hydroxytestosterone formation. Whole liver mRNA samples exhibited significant induction in CYP2B1/2 transcript levels: sixfold for PB and 2200-fold for dieldrin. All the LCM band samples also showed significant fold induction in CYP2B1/2 mRNA compared to controls. Dieldrin caused marked increases in CYP2B1/2 mRNA levels in the direction of blood flow through the acinus: periportal, 300-fold; midzonal, 600-fold; and centrilobular, 1700-fold. A different pattern of induction was observed in the PB-treated rats: periportal, 1800-fold; midzonal, 8800-fold; and centrilobular, 1600-fold. The present study indicates the differences in spatial responses that can be exhibited within the liver following exposure to various xenobiotics. It also indicates the importance of examining xenobiotic metabolism in the liver in light of its nonhomogeneous, zoned microenvironment. © The Author 2007.

Kumar, S., Buza, J. J., & Burgess, S. C. (2009). Genotype-dependent tumor regression in Marek's disease mediated at the level of tumor immunity. Cancer Microenvironment, 2(1), 23-31.

PMID: 19308678;PMCID: PMC2787926;Abstract:

Marek's disease (MD) of chickens is a unique natural model of Hodgkin's and Non Hodgkin's lymphomas in which the neoplastically-transformed cells over-express CD30 (CD30hi) antigen. All chicken genotypes can be infected with MD virus and develop microscopic lymphomas. From 21 days post infection (dpi) microscopic lymphomas regress in resistant chickens but, in contrast, they progress to gross lymphomas in susceptible chickens. Here we test our hypothesis that in resistant chickens at 21 dpi the tissue microenvironment is pro T-helper (Th)-1 and compatible with cytotoxic T lymphocyte (CTL) immunity but in susceptible lines it is pro Th-2 or pro T-regulatory (T-reg) and antagonistic to CTL immunity. We used the B2, non-MHC-associated, MD resistance/susceptibility system (line [L]61/line [L]72) and quantified the levels of key mRNAs that can be used to define Th-1 (IL-2, IL-12, IL-18, IFNγ), Th-2 (IL-4, IL-10) and T-reg (TGFβ, GPR-83, CTLA-4, SMAD-7) lymphocyte phenotypes. We measured gene expression in both whole tissues (represents tissue microenvironment and tumor microenvironment) and in the lymphoma lesions (tumor microenvironment) themselves. Gene ontology-based modeling of our results shows that the dominant phenotype in whole tissue as well as in microscopic lymphoma lesions, is pro T-reg in both L61 and L72 but a minor pro Th-1 and anti Th-2 tissue microenvironment exists in L61 whereas there is an anti Th-1 and pro Th-2 tissue microenvironment in L72. The tumor microenvironment per se is pro T-reg, anti Th-1 and pro Th-2 in both L61 and L72. Together our data suggests that the neoplastic transformation is essentially the same in both L61 and L72 and that resistance/ susceptibility is mediated at the level of tumor immunity in the tissues. © 2009 Springer Science+Business Media B.V.